AFM Portaal en AFM-website niet bereikbaar komend weekend
Vanaf vrijdag 4 oktober 21.00 uur tot zondag 6 oktober 21.00 uur is het AFM Portaal niet bereikbaar. Vanaf zaterdag 5 oktober 06.00 uur tot zondag 6 oktober 21.00 uur is de AFM-website niet bereikbaar.
Koninklijke Philips N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
06 jul 2007 - 08:06
Statutaire naam
Koninklijke Philips N.V.
Titel
Philips notified of filing of MedQuist audited financial statements for the period 2003 to 2005
Bericht
July 6, 2007
PHILIPS NOTIFIED OF FILING OF MEDQUIST AUDITED
FINANCIAL STATEMENTS FOR THE PERIOD 2003 TO 2005
Amsterdam, The Netherlands – Royal Philips Electronics (NYSE:PHG, AEX:PHI) was informed that yesterday MedQuist Inc. (Pink Sheets: MEDQ.PK) announced the filing with the United States Securities and Exchange Commission (SEC) of its Form 10-K Annual Report for the year ended December 31, 2005. The filing contains annual and quarterly financial information of MedQuist for the years ended December 31, 2005, 2004 and 2003. The financial information contained in MedQuist’s Form 10-K filing has no material impact on the financial information contained in Philips’ Annual Reports for the years 2005, 2004 and 2003.
In its announcement, MedQuist has also indicated that it is now immediately shifting its attention to completing the work on its remaining outstanding SEC filings, which MedQuist anticipates filing during the third quarter of 2007. The MedQuist announcement can be found on the MedQuist internet site at http://www.medquist.com. The filing can be found on the SEC’s website at http://www.sec.gov.
In commenting on MedQuist’s announcement of the filing with the SEC, Pierre-Jean Sivignon, Chief Financial Officer of Royal Philips Electronics, said: “We’re very pleased to see that MedQuist has taken this major step forward in its filings with the SEC. In light of this progress, Philips is reviewing all of its future options for its approximate 70% stake in MedQuist, as Philips views this stake as a non-core holding.” To this end, Philips is making an amendment to its Schedule 13D filing with the SEC, in which Philips indicates it may consider possible transactions or other changes in its ownership stake in MedQuist.
In accordance with US GAAP accounting standards, Philips annually tests goodwill for impairment in the second quarter. As a result of the test of its MedQuist-related goodwill, Philips will recognize a non-cash impairment charge of approximat
Gerelateerde downloads
Datum laatste update: 06 oktober 2024